Medicare and Medicaid Administrator Dr. Mehmet Oz speaks in the Oval Office in Washington on Nov. 6, 2025. Andrew Caballero-Reynolds/AFP via Getty Images
Medicare will keep covering popular glucagon-like peptide-1 drugs through the end of 2027, the Centers for Medicare and Medicaid Services (CMS) said on April 21.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
Read Full Article: https://www.theepochtimes.com/us/medicare-extends-interim-coverage-of-weight-loss-drugs-suspends-pilot-program-6015573/?utm_source=partner&utm_campaign=whatfinger
